One cause of IR in NAFLD is mediated by impaired insulin signaling pathway, for example, impairment of the insulin receptor substrate (IRS)-1/Akt/glycogen synthase kinase (GSK) 3β pathway6. This evidence concerns the gene IRS1 and metabolic dysfunction-associated steatotic liver disease.